Merck 2010 Annual Report Download - page 28
Download and view the complete annual report
Please find page 28 of the 2010 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18 -
19 -
20 -
21 -
22 -
23 -
24 -
25 -
26 -
27 -
28 -
29 -
30 -
31 -
32 -
33 -
34 -
35 -
36 -
37 -
38 -
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
-
215
-
216
-
217
-
218
-
219
-
220
-
221
-
222
-
223
 |
 |
EUR million
10,000
7,500
5,000
2,500
2006* 2007 2008 2009 2010
Europe North America Latin America Asia, Africa, Australasia
With sales of EUR 2,305 million, Asia is our second largest region and is increasingly gaining
in importance, growing by 37% in 2010. In Asia, Taiwan is the leading country by sales for the
Merck Group. Sales there increased by 75% to EUR 589 million following a weak 2009, mainly
as a result of the Liquid Crystals business. The Chemicals business was responsible for 94% of
sales in Taiwan, with the Liquid Crystals business accounting for the largest share.
Our second-largest market in Asia is Japan, where we posted a 57% increase in sales to
EUR 486 million. The Pharmaceuticals business sector accounts for about 40% and the Chemi-
cals business sector for around 60% of sales. The sales growth rates achieved by Pharmaceu-
ticals and Chemicals varied, amounting to 39% and 71%, respectively.
South Korea is our third-largest Asian market. Sales increased here by 3.9% to EUR 360 million.
The focus is on the Chemicals business, which accounted for 89% of sales.
Our declared growth market of China currently ranks fourth within Asia. We achieved a 26%
increase in sales in this market to EUR 240 million. Sales in China are about evenly divided
between our Pharmaceuticals and Chemicals business sectors. In India, which follows China
in our sales ranking, we achieved sales growth of 38% to EUR 156 million. Pharmaceuticals
accounted for 27% and Chemicals for 73% of sales.
Merck expanded sales in North America to EUR 1,530 million in 2010. This represents growth
of 31%. At EUR 1,403 million (+31%), more than 90% of sales in this region are generated
in the United States. The Pharmaceuticals business sector accounts for around 70% and the
Chemicals business sector for around 30% of sales in the United States. This ratio will continue
to shift in favor of Chemicals owing to the acquisition of Millipore in mid-2010.
In Latin America, Brazil is by far our largest market, followed by Mexico. Brazil is one of our
declared growth markets besides India and China. In 2010, we increased our sales in Brazil by
37% to EUR 359 million. Around 80% of sales there were generated by the Pharmaceuticals
business sector.
On July 14, 2010, Merck successfully completed the acquisition of Millipore Corporation,
a leading life science company based in Billerica, Massachusetts, USA. The Millipore companies
Focus on Asian markets
Merck Annual Report 2010 24